Brief: Biohit Keeps 2024 Outlook Unchanged

Biohit Oyj

07/08/2024 09:10

Aug 7 (Reuters) - Biohit Oyj  BIOBV.HE :
    * H1 REVENUE EUR 7.4 MILLION (EUR 6.5 MILLION), AN INCREASE
OF
14,0%
    * H1 EBIT EUR 1.3 MILLION (EUR 1.5 MILLION) 17.8% (23.2%) OF
REVENUE
    * TARGETS FOR 2024–2028: REVENUE GROWTH 15–20% ANNUALLY
OPERATING
PROFIT (EBIT) AT LEAST 10% OF REVENUE
    * 2024 OUTLOOK UNCHANGED


Further company coverage:  BIOBV.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))